gefitinib has been researched along with tolonium chloride in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (tolonium chloride) | Trials (tolonium chloride) | Recent Studies (post-2010) (tolonium chloride) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,913 | 34 | 493 |
| Protein | Taxonomy | gefitinib (IC50) | tolonium chloride (IC50) |
|---|---|---|---|
| Microtubule-associated protein tau | Homo sapiens (human) | 0.069 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajiki, T; Digiovanni, J; Kawamoto, T; Kiguchi, K; Ruffino, L | 1 |
1 other study(ies) available for gefitinib and tolonium chloride
| Article | Year |
|---|---|
Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Blotting, Western; Body Weight; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gallbladder; Gallbladder Neoplasms; Gefitinib; Humans; In Situ Nick-End Labeling; MAP Kinase Signaling System; Mice; Mice, Transgenic; Microscopy, Fluorescence; Neoplasms, Experimental; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Receptor, ErbB-2; Tolonium Chloride | 2005 |